Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3271482 | 0.89 | ABCC4 (0.40) | ALDH1A1USP2LMNACYP1A2TSHR | |
| SCHEMBL225199 | 0.81 | ALDH1A1 (0.57) | ALDH1A1USP2LMNACYP1A2TSHR | |
| SCHEMBL30016277 | 0.80 | CYP2C19 (0.41) | ALDH1A1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL15538586 | 0.80 | LMNA (0.46) | ALDH1A1USP2LMNACYP1A2TSHR | |
| SCHEMBL14390606 | 0.79 | ALDH1A1 (0.53) | ALDH1A1USP2LMNACYP1A2TSHR | |
| SCHEMBL9013770 | 0.77 | KDM4E (0.37) | ALDH1A1LMNACYP1A2TSHRMEN1 | |
| SCHEMBL34475704 | 0.76 | MEN1 (0.31) | ALDH1A1MEN1KMT2APOLB | |
| SCHEMBL30569789 | 0.75 | CYP2C19 (0.48) | ALDH1A1LMNASMN1; SMN2MEN1KMT2A | |
| SCHEMBL3961575 | 0.75 | POLB (0.33) | ALDH1A1USP2LMNACYP1A2TSHR | |
| SCHEMBL3960623 | 0.75 | POLB (0.33) | ALDH1A1USP2LMNACYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 384 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3052551-B1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | ENCAPSYS LLC (US) | 2021-12-01 | — | — | EP | claimed |
| US-10920170-B2 | Fragrance mixtures containing tricyclo[5.2.1.0]-decane-8-ethyl ether | SYMRISE AG (DE) | 2021-02-16 | — | — | US | claimed |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SYMRISE AG (DE) | 2020-12-29 | — | — | US | claimed |
| EP-3423028-B1 | METHOD FOR THE PRODUCTION OF ENCAPSULATED FRAGRANCE WITH IMPROVED STABILITY AGAINST DETERGENTS | SYMRISE AG (DE) | 2020-04-08 | — | — | EP | claimed |
| US-20200063063-A1 | FRAGRANCE MIXTURES CONTAINING TRICYCLO[5.2.1.0]-DECANE-8-ETHYL ETHER | SYMRISE AG (DE) | 2020-02-27 | — | — | US | claimed |
| EP-2160176-B1 | BENEFIT AGENT CONTAINING DELIVERY PARTICLE | PROCTER & GAMBLE (US) | 2017-07-26 | — | — | EP | claimed |
| US-9340751-B2 | Use of specific compounds for modifying odors | SYMRISE AG (DE) | 2016-05-17 | — | — | US | claimed |
| EP-2174645-B1 | Materials containing aromas incorporating cetyl nonanoate and/or stearyl nonanoate | SYMRISE AG (DE) | 2015-07-29 | — | — | EP | claimed |
| US-20150182656-A1 | Perfume Compositions | GIVAUDAN S.A. (CH) | 2015-07-02 | — | — | US | claimed |
| US-8999913-B2 | Fragrance mixtures containing cyclopent-2-enyl ethyl acetate | SYMRISE AG (DE) | 2015-04-07 | — | — | US | claimed |
| EP-1360269-B1 | AUTOMATIC DISHWASHING COMPOSITIONS COMPRISING DIACYL PEROXIDE BLEACH AND BLOOMING PERFUME | PROCTER & GAMBLE (US) | 2005-08-03 | — | — | EP | claimed |
| EP-1282368-B1 | AMBIENT STABLE BEVERAGE | UNILEVER PLC (GB) | 2005-07-27 | — | — | EP | claimed |
| EP-0991327-B1 | MICROORGANISM REDUCTION METHODS AND COMPOSITIONS FOR FOOD CLEANING | PROCTER & GAMBLE (US) | 2004-12-01 | — | — | EP | claimed |
| US-20030104969-A1 | Laundry system having unitized dosing | PROCTER & GAMBLE COMPANY,THE | 2003-06-05 | — | — | US | claimed |
| EP-0787176-B1 | FABRIC SOFTENER COMPOSITIONS WITH REDUCED ENVIRONMENTAL IMPACT | PROCTER & GAMBLE (US) | 2003-05-07 | — | — | EP | claimed |
| EP-1297101-A2 | LAUNDRY SYSTEM HAVING UNITIZED DOSING | THE PROCTER & GAMBLE COMPANY (US) | 2003-04-02 | — | — | EP | claimed |
| EP-1280882-A1 | HIGHLY CONCENTRATED FABRIC SOFTENER COMPOSITIONS AND ARTICLES CONTAINING SUCH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2003-02-05 | — | — | EP | claimed |
| WO-2001085892-A1 | HIGHLY CONCENTRATED FABRIC SOFTENER COMPOSITIONS AND ARTICLES CONTAINING SUCH COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-15 | — | — | WO | claimed |
| WO-2001085888-A2 | LAUNDRY SYSTEM HAVING UNITIZED DOSING | THE PROCTER & GAMBLE COMPANY (US) | 2001-11-15 | — | — | WO | claimed |
| US-5445747-A | Containing fabric softener, perfume selected to cover odors | THE PROCTER & GAMBLE COMPANY (US) | 1995-08-29 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10920170-B2 | Fragrance mixtures containing tricyclo[5.2.1.0]-decane-8-ethyl ether | CCT8, F8, TRPM8 | ALDH1A1 370/4885USP2 3550/4885LMNA 3294/4885 |
| US-20200063063-A1 | FRAGRANCE MIXTURES CONTAINING TRICYCLO[5.2.1.0]-DECANE-8-ETHYL ETHER | CCT8, F8, TRPM8 | ALDH1A1 370/4885USP2 3550/4885LMNA 3294/4885 |
| US-10876081-B2 | Method for the production of scent capsules with improved surfactant stability | SMOX, LIPA, SGMS2 | ALDH1A1 804/4885USP2 760/4885LMNA 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.